Cambridge Trust’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History

Cambridge Trust’s Portfolio CMPI Stock Details CMPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-24,609	Closed	-$79K	–	982
2022 Q1	$79K	Hold	24,609	–	–	﹤0.01%	464
2021 Q4	$71K	Hold	24,609	–	–	﹤0.01%	478
2021 Q3	$98K	Hold	24,609	–	–	﹤0.01%	269
2021 Q2	$147K	Hold	24,609	–	–	0.01%	272
2021 Q1	$299K	Buy	+24,609	New	+$350K	0.01%	217

Cambridge Trust's CMPI Position: Q2 2022 in Review

Cambridge Trust sold out of Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) in Q2 2022, closing a stake of 24,609 shares — an estimated $79K sold.

Cambridge Trust first reported a position in CMPI in Q1 2021 and held it in 5 quarters. The position peaked at $299K in Q1 2021. 0 funds tracked by Wall St. Rank hold CMPI as of Q2 2022.

Cambridge Trust reported no remaining Checkmate Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Cambridge Trust sold 24,609 Checkmate Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $79K.
Cambridge Trust first reported a position in Checkmate Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Cambridge Trust's Checkmate Pharmaceuticals, Inc. Common Stock position peaked at $299K in Q1 2021.
0 funds tracked by Wall St. Rank held Checkmate Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Cambridge Trust's 13F filing for Q2 2022, filed 16 Aug 2022.